Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry

被引:77
作者
Ribeiro, Ligia N. M. [1 ]
Franz-Montan, Michelle [2 ]
Breitkreitz, Marcia C. [3 ]
Alcantara, Ana C. S. [4 ]
Castro, Simone R. [1 ]
Guilherme, Viviane A. [1 ]
Barbosa, Raquel M. [5 ,6 ]
de Paula, Eneida [1 ]
机构
[1] State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Rua Monteiro Lobato 225, BR-13083862 Sao Paulo, Brazil
[2] Univ Estadual Campinas, Sch Dent, Dept Physiol Sci, Sao Paulo, Brazil
[3] Univ Estadual Campinas, Inst Chem, Dept Analyt Chem, Sao Paulo, Brazil
[4] Univ Fed Maranhao, Dept Chem, Sao Luis, Maranhao, Brazil
[5] Kings Coll London, Inst Pharmaceut Sci, Sch Biomed Sci, Guys Hosp, London WC2R 2LS, England
[6] Kings Coll London, Inst Pharmaceut Sci, Sch Biomed Sci, St Thomas Hosp, London WC2R 2LS, England
关键词
Dentistry; Nanostructured lipid carriers; Lidocaine; Prilocaine; Factorial design; CONTROLLED DRUG-DELIVERY; DYNAMIC LIGHT-SCATTERING; TRACKING ANALYSIS NTA; NANOPARTICLES SLN; PHYSICAL STABILITY; EUTECTIC MIXTURE; IN-VITRO; NLC; HYDROCHLORIDE; MUCOSA;
D O I
10.1016/j.ejps.2016.08.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In dental practice, local anesthesia causes pain, fear, and stress, and is frequently the reason that patients abandon treatment. Topical anesthetics are applied in order to minimize the discomfort caused by needle insertion and injection, and to reduce the symptoms of superficial trauma at the oral mucosa, but there are still no efficient commercially available formulations. Factorial design is a multivariate data analysis procedure that can be used to optimize the manufacturing processes of lipid nanocarriers, providing valuable information and minimizing development time. This work describes the use of factorial design to optimize a process for the preparation of nano structured lipid carriers (NLC) based on cetyl palmitate and capric/caprylic triglycerides as structural lipids and Pluronic 68 as the colloidal stabilizer, for delivery of the local anesthetics lidocaine and prilocaine (both at 2.5%). The factors selected were the excipient concentrations, and three different responses were followed: particle size, polydispersity index and zeta potential. The encapsulation efficiency of the most effective formulations (NLC 2, 4, and 6) was evaluated by the ultrafiltration/centrifugation method. The formulations that showed the highest levels of encapsulation were tested using in vitro release kinetics experiments with Franz diffusion cells. The NLC6 formulation exhibited the best sustained release profile, with 59% LDC and 66% PLC released after 20 h. This formulation was then characterized using different techniques (IR-ATR, DSC, DRX, TEM, and NTA) to obtain information about its molecular organization and its physicochemical stability, followed during 14 months of storage at 25 degrees C. This thorough pre-formulation study represents an important advance towards the development of an efficient pre-anesthetic for use in dentistry. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:192 / 202
页数:11
相关论文
共 77 条
[1]   In vitro drug release mechanism from lipid nanocapsules (LNC) [J].
Abdel-Mottaleb, Mona M. A. ;
Neumann, Dirk ;
Lamprecht, Alf .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 390 (02) :208-213
[2]   Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: Evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy (1H NMR) [J].
Ali, Hazem ;
El-Sayed, Khalid ;
Sylvester, Paul W. ;
Nazzal, Sami .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 77 (02) :286-297
[3]   Hydrophilic Polymers for Modified-Release Nanoparticles: A Review of Mathematical Modelling for Pharmacokinetic Analysis [J].
Andreani, Tatiana ;
Fangueiro, Joana F. ;
Jose, Sajan ;
Santini, Antonello ;
Silva, Amelia M. ;
Souto, Eliana B. .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (22) :3090-3096
[4]  
Aranda P., 2012, P SPIE NANOSYSTEMS E
[5]  
Attama AA, 2012, RECENT ADVANCES IN NOVEL DRUG CARRIER SYSTEMS, P107, DOI 10.5772/50486
[6]   Cytotoxicity of solid lipid nanoparticles and nanostructured lipid carriers containing the local anesthetic dibucaine designed for topical application [J].
Barbosa, R. M. ;
da Silva, C. M. G. ;
Bella, T. S. ;
de Araujo, D. R. ;
Marcato, P. D. ;
Duran, N. ;
de Paula, E. .
NANOSAFE 2012: INTERNATIONAL CONFERENCES ON SAFE PRODUCTION AND USE OF NANOMATERIALS, 2013, 429
[7]  
BASHA M, 2015, CURR DRUG DELIV, V12, P1
[8]   Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery [J].
Battaglia, Luigi ;
Gallarate, Marina .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (05) :497-508
[9]   Development of an Ointment Formulation Using Hot-Melt Extrusion Technology [J].
Bhagurkar, Ajinkya M. ;
Angamuthu, Muralikrishnan ;
Patil, Hemlata ;
Tiwari, Roshan V. ;
Maurya, Abhijeet ;
Hashemnejad, Seyed Meysam ;
Kundu, Santanu ;
Murthy, S. Narasimha ;
Repka, Michael A. .
AAPS PHARMSCITECH, 2016, 17 (01) :158-166
[10]   Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-β-cyclodextrin [J].
Bragagni, Marco ;
Maestrelli, Francesca ;
Mura, Paola .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2010, 68 (3-4) :437-445